|
| Product | Alternate Name | Type | Strength | Quantity | Price (USD) | Buy Now | |
 |
Proamatine |
midodrine |
Brand |
5mg |
100TAB |
$130.00 |
|
|
|
 Save. Save. Save. On Proamatine and more!
Express-medicine.com provides customers like you access to popular top-quality pharmaceuticals at truly competitive prices. Saving you up to 80% on hundreds of medications from our Express Medicine pharmacy!
No Surprises - all your medications will come from licensed pharmacies. Your satisfaction is guaranteed. All our brand & generic products are FDA approved.
-
2009-10-27 09:50:00
Congressional investigators let their voices be heard when they announced that the FDA has allowed drugs for cancer and other diseases to remain on the market even when follow-up studies confirmed that they didn’t extend patients’ lives. A report due out on October 26, 2009, from the Government Acco ...
-
2009-10-27 07:41:00
Did you know that the Food and Drug Administration has never pulled a drug off the market simply because the drug doesn't provide the benefits the manufacturer claimed it would? I have to admit I didn't know that either, until I read an Associated Press article about an upcoming report from the Gove ...
-
2009-10-26 17:10:00
Here’s a reasonable idea: Create an accelerated process to approve new, potentially life-saving drugs — and build in post-approval requirements to make sure the drugs really work. The FDA put in place the first part in the early 1990s, but hasn’t been so good at the follow-up, according to a GAO rep ...
-
2009-10-26 15:18:00
GAO STUDY OF ‘ACCELERATED APPROVAL’ Ineffective drugs never pulled by FDA By Matthew Perrone ASSOCIATED PRESS WASHINGTON — The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn’t save lives, congressional i ...
-
2009-10-26 14:55:00
By MATTHEW PERRONE (AP) – 13 hours ago WASHINGTON — The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn’t extend patients’ lives, say congressional investigators. A report due out Monday from the Governme ...
-
2009-10-26 08:24:00
The agency has allowed drugs to remain available even when follow-up studies showed they didn’t save lives, according to a report due today from the General Accountability Office. And the FDA has never pulled a drug off the market due to a lack of required follow-up about its actual benefits — even ...
-
2009-10-26 01:44:00
This is a interesting post from YAHOO health....just as FYI...Net, one must be careful what you take! Here I am wanting to get PRRT approved by the FDA, and this articles outlines FDA approved drugs that either don't work or our needing additional information and never received!!! On the plus side, ...
|